Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025)
Syndax Pharmaceuticals' (SNDX) quarterly Capital Expenditures came in at $56000.0 in Q4 2025, up 300.0% quarter-over-quarter from $14000.0 in Q4 2018.
Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025) Analysis & Trends
Syndax Pharmaceuticals' Capital Expenditures history runs 5 years deep, the most recent figure standing at $56000.0 for Q4 2025.
- On a quarterly basis, Capital Expenditures changed N/A year-over-year to $56000.0 in Q4 2025; TTM through Dec 2025 was $70000.0, a 400.0% increase from a year earlier, with the FY2025 full-year figure at $187000.0, changed N/A from the prior year.
- Capital Expenditures advanced to $56000.0 in Q4 2025 per SNDX's latest filing, from $14000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $56000.0 in Q4 2025 and bottomed at $56000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Mar 31, 2018 | 173,000.00 |
| Mar 31, 2018 | 173,000.00 |
| Dec 31, 2017 | 42,000.00 |
| Dec 31, 2017 | 42,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Sep 30, 2016 | 55,000.00 |
| Sep 30, 2016 | 55,000.00 |
| Jun 30, 2016 | 133,000.00 |
| Jun 30, 2016 | 133,000.00 |
| Mar 31, 2016 | 73,000.00 |
| Mar 31, 2016 | 73,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Sep 30, 2015 | 13,000.00 |
| Sep 30, 2015 | 13,000.00 |